TGTX financials
TG Therapeutics (TGTX) financials: revenue, profit and margins by year and quarter, the balance sheet and cash flow.
TGTX income statement, yearly
| Year | Revenue | Gross profit | Operating income | Net income | EPS |
|---|---|---|---|---|---|
| 2025 | $616.29M | $515.57M | $123.32M | $447.18M | 2.77 |
| 2024 | $329.00M | $290.52M | $41.93M | $23.38M | 0.15 |
| 2023 | $233.66M | $219.53M | $20.63M | $12.67M | 0.09 |
| 2022 | $2.79M | $2.52M | -$218.32M | -$223.81M | -1.46 |
| 2021 | $6.69M | $5.90M | -$344.77M | -$348.10M | -2.63 |
| 2020 | $152.00K | $152.00K | -$273.59M | -$279.38M | -2.42 |
- TGTX revenue was $616.29M in fiscal 2025, net income $447.18M.
Updated 2026-11-02 17:55 UTC